Cervarix® U.S. regulatory update
GlaxoSmithKline submits final study data to FDA for cervical cancer vaccine
Read the full articleYou might also wanna read
Phase Ib/IIa Open-label Study, to Evaluate Safety, Tolerability, and Antitumor Activity of HCB101 in Combination With Multiple Agents in Subjects With Advanced Gastric or Gastro-esophageal (GEJ) Adenocarcinoma
Conditions : GC/GEJC Interventions : Biological: Zolbetuximab; Drug: Oxaliplatin + 5-Fluorouracil/Leucovorin; Drug: CAPOX (oxaliplatin/capec
HPV Vaccine at 20: Proven Cancer Prevention Tool Faces Uptake Challenges
Evidence supports HPV vaccination as a powerful cancer prevention tool, but improving its uptake remains critical for achieving long-term pu
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of VG2025 Intravenous Injection in Subjects With Advanced Solid Tumors
Conditions : Advanced Malignant Solid Tumor Interventions : Drug: Recombinant Human IL12/15 Dual-Regulated Oncolytic HSV-1 Injection Sponsor
PanCAN Statement on Positive Overall Survival Results from Revolution Medicines Phase III Trial at ASCO
Jun 1, 2026 - By Julie Vasquez The Pancreatic Cancer Action Network (PanCAN), the leading organization dedicated to advancing progress again

World’s First CE-Certification for Whole-Genome Cancer Dx Software
IVDR certification for the Hartwig Medical Foundation’s OncoAct software covers a workflow that spans raw sequencing to treatment and clinic
FDA advisory panel recommends updating fall Covid vaccines to target XFG variant
The advisory panel recommended updating this fall’s Covid shots to target the XFG variant, a fast-growing strain nicknamed “stratus.”

Comments
Sign in to join the conversation.
No comments yet. Be the first.